These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
481 related items for PubMed ID: 19068724
21. [Clinical research on prevention of recurrence of superficial bladder cancer--comparative study on clinical efficacy of bleomycin intravesical instillation and bestatin]. Kumamoto Y, Tsukamoto T, Tamiya T, Takatsuka K, Furuya S, Yokoyama E, Honma A, Aoyama T, Tanda H, Kato S. Hinyokika Kiyo; 1985 Oct; 31(10):1861-83. PubMed ID: 2418659 [Abstract] [Full Text] [Related]
22. [Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time]. Nonomura N, Nishimura K, Okuyama A, Miki T, Kishimoto T, Kiyohara H, Wakatsuki A, Fujioka H, Kuroda H, Nakano E, Takeyama M, Koide T, Yamaguchi S. Hinyokika Kiyo; 2001 May; 47(5):315-9. PubMed ID: 11433751 [Abstract] [Full Text] [Related]
23. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. Divrik RT, Yildirim U, Zorlu F, Ozen H. J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720 [Abstract] [Full Text] [Related]
24. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin]. Hinotsu S, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Matsumura Y, Niijima T, Obata K, Ohashi Y, Ohe H, Shimazaki J, Tashiro K, Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin. Gan To Kagaku Ryoho; 2002 Jan; 29(1):73-80. PubMed ID: 11816482 [Abstract] [Full Text] [Related]
25. [Clinical efficacy of post-TUR prophylactic chemotherapy for superficial bladder cancer--the result of co-operative prospective randomized trial]. Takahashi Y, Kuriyama M, Yamada S, Fujimoto Y, Takeuchi T, Doi T, Sakai S, Isogai K, Kanematsu M, Hayashi H, Fujihiro S, Hasegawa Y, Ehara H, Maeda S, Itoh F, Kobayashi S, Horie M, Matsuda S, Takeda A, Tei KH, Kawada Y. Gan To Kagaku Ryoho; 1997 Sep; 24(12):1817-9. PubMed ID: 9382540 [Abstract] [Full Text] [Related]
26. [Effect of prophylactic treatment with intravesical epirubicin in recurrence of superficial bladder tumor]. Pérez Mestre M, Cuñat Albert E, Francisco Mingol V, Arrufat Boix JM, Gallego Gómez J. Arch Esp Urol; 1999 May; 52(4):345-50. PubMed ID: 10380324 [Abstract] [Full Text] [Related]
29. [Intravesical instillation of epirubicin hydrochloride in superficial bladder tumor--prophylactic and therapeutic instillation for carcinoma in situ]. Shichiri Y, Kanba T, Yoshida S, Arai Y. Hinyokika Kiyo; 1995 May; 41(5):359-64. PubMed ID: 7598036 [Abstract] [Full Text] [Related]
31. [Postoperative intravesical instillation of THP for superficial bladder tumor: clinical results of prophylactic effects on the recurrence. Fukushima THP Research Group]. Aikawa K, Irisawa C, Muraki O, Yamaguchi O, Shiraiwa Y, Noguchi M, Koguchi M, Yokoyama J, Ito K, Kumakawa K. Gan To Kagaku Ryoho; 1992 Apr; 19(4):509-13. PubMed ID: 1558401 [Abstract] [Full Text] [Related]
32. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. Di Stasi SM, Valenti M, Verri C, Liberati E, Giurioli A, Leprini G, Masedu F, Ricci AR, Micali F, Vespasiani G. Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711 [Abstract] [Full Text] [Related]
33. A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences. Berrum-Svennung I, Granfors T, Jahnson S, Boman H, Holmäng S. J Urol; 2008 Jan; 179(1):101-5; discussion 105-6. PubMed ID: 17997459 [Abstract] [Full Text] [Related]
34. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. Hinotsu S, Akaza H, Isaka S, Kanetake H, Kubota Y, Kuroda M, Shinohara N, Shinka T, Tachibana M, Naito S, Hirao Y, BCG Tokyo 172 Strain Study Group. Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576 [Abstract] [Full Text] [Related]
35. [A clinical study of recurrence and progression of grade 3 superficial bladder tumor]. Ikegami S, Tsuji A, Suzuki S, Sumitomo M, Kimura F, Asano T, Nakajima F, Hayakawa M. Hinyokika Kiyo; 1999 May; 45(5):325-9. PubMed ID: 10410314 [Abstract] [Full Text] [Related]
37. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence]. Ding GQ, Shen ZJ, Lu J, Jin XD, Chen J, Shi SF. Zhonghua Wai Ke Za Zhi; 2005 Nov 15; 43(22):1457-60. PubMed ID: 16318813 [Abstract] [Full Text] [Related]
38. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis. Uchida A, Yonou H, Hayashi E, Iha K, Oda M, Miyazato M, Oshiro Y, Hokama S, Sugaya K, Ogawa Y. Urology; 2007 Feb 15; 69(2):275-9. PubMed ID: 17320663 [Abstract] [Full Text] [Related]
40. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association. Int J Urol; 2009 Mar 15; 16(3):279-86. PubMed ID: 19207609 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]